enGene Therapeutics Inc. (NASDAQ:ENGN)
| Market Cap | 116.90M-76.5% |
| Revenue (ttm) | 0 |
| Net Income | -4.90M+94.8% |
| EPS | -0.28+85.3% |
| Shares Out | 66.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Feb 2, 2015 |
| Volume | 708,286 |
| Open | 1.78 |
| Previous Close | 1.80 |
| Day's Range | 1.74 - 1.86 |
| 52-Week Range | 1.40 - 12.25 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 3.00(+71.92%) |
| Earnings Date | Dec 28, 2026 |
enGene Therapeutics Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About ENGN
Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ENGN stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ENGN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ENGN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ENGN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ENGN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ENGN from public contracts
Source: USAspending.gov
ENGN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ENGN’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score